Viewing Study NCT01398592


Ignite Creation Date: 2025-12-24 @ 3:35 PM
Ignite Modification Date: 2026-01-19 @ 8:29 PM
Study NCT ID: NCT01398592
Status: COMPLETED
Last Update Posted: 2013-02-12
First Post: 2011-07-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vildagliptin Versus Sitagliptin - Differences in Fasting Plasma Glucose Lowering Efficacy
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes mellitus Type two View
None T2DM View
None vildagliptin View
None sitagliptin View
None FPG View
None DPP-4 View